Literature DB >> 9884350

Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions.

J Rohrer1, Y Minegishi, D Richter, J Eguiguren, M E Conley.   

Abstract

Mutations in Bruton's tyrosine kinase (Btk) result in the immunodeficiency X-linked agammaglobulinemia (XLA). In a previous study of 101 patients with presumed XLA, we identified seven patients with large genomic alterations in Btk. The recent completion of 100 kb of contiguous DNA sequence at the Btk locus has allowed us to characterize these mutations in detail and to identify four different types of alterations. These alterations included a 253-bp retroposon insertion at position +5 within intron 9, an inversion of greater than 48 kb that disrupted Btk between exons 4 and 5, a 12.9-kb duplication including Btk exons 2 to 5, and four deletions ranging from 2.8 to 38 kb in size. The duplication and three of the deletions resulted from unequal crossovers of Alu repeats. Further, three of the deletions terminated within a repeat-rich cluster spanning 30 kb of sequence 3' of Btk exon 19, suggesting that this region was more susceptible to unequal crossovers than the rest of the Btk gene. These studies describe the first reports of an insertion, an inversion, and a duplication in Btk and demonstrate the utility of large-scale sequencing in the elucidation of disease-causing mutations. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9884350     DOI: 10.1006/clim.1998.4629

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  22 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

4.  A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.

Authors:  M E Conley; D M Farmer; A K Dobbs; V Howard; Y Aiba; S A Shurtleff; T Kurosaki
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

5.  5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome.

Authors:  Annette Damert; Julija Raiz; Axel V Horn; Johannes Löwer; Hui Wang; Jinchuan Xing; Mark A Batzer; Roswitha Löwer; Gerald G Schumann
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

6.  Mobilizing diversity: transposable element insertions in genetic variation and disease.

Authors:  Kathryn A O'Donnell; Kathleen H Burns
Journal:  Mob DNA       Date:  2010-09-02

7.  Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion.

Authors:  Lawrence R Shiow; Kenneth Paris; Matthew C Akana; Jason G Cyster; Ricardo U Sorensen; Jennifer M Puck
Journal:  Clin Immunol       Date:  2008-12-20       Impact factor: 3.969

8.  Exon-trapping mediated by the human retrotransposon SVA.

Authors:  Dustin C Hancks; Adam D Ewing; Jesse E Chen; Katsushi Tokunaga; Haig H Kazazian
Journal:  Genome Res       Date:  2009-07-27       Impact factor: 9.043

9.  Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.

Authors:  Eun-Kyeong Jo; Yue Wang; Hirokazu Kanegane; Takeshi Futatani; Chang-Hwa Song; Jeong-Kyu Park; Jung Soo Kim; Dong Soo Kim; Kang-Mo Ahn; Sang-Il Lee; Hyeon Jin Park; Youn Soo Hahn; Jae-Ho Lee; Toshio Miyawaki
Journal:  J Hum Genet       Date:  2003-05-24       Impact factor: 3.172

10.  SVA elements are nonautonomous retrotransposons that cause disease in humans.

Authors:  Eric M Ostertag; John L Goodier; Yue Zhang; Haig H Kazazian
Journal:  Am J Hum Genet       Date:  2003-11-19       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.